Abstract:Aim: To observe the changes of serum interleukin-8, monocyte chemoattractant protein-1and interleukin-10 in patients with obstructive sleep apnea hypopnea syndrome (OSAHS), and to explore the significance. Methods: Thirty-five patients with obstructive sleep apnea hypopnea syndrome confirmed by polysomnography, who hospitalized in Department of Respiratory Medicine, First Hospital of Lanzhou University from December 2002 to December 2003, were selected. Ten with moderate and severe OSAHS of these patients had been treated by nasal continuous positive air pressure for over half a year, were selected as treatment group aged (51 ±13) years old. The included patients all knew the fact of the treatment program and agreed. Twenty-five healthy subjects in this hospital were recruited as the control group during the same period, and agreed to take part in the experiment. The apnea hypopnea index and lowest blood oxygen saturation were detected by the Polywin polysomnography. The serum levels of interleukin-8, interleukin-10 and monocyte chemoattractant protein-1 were measured by enzyme linked immune sandwich assay. The patients with moderate and severe OSAHS were treated with continuous positive airway. The pressure of nasal continuous positive airway was 0.588-1.176 kPa for 6-8 hours every day. The t-test was performed among the comparison of groups, and the paired t-test was conducted among the comparison within the groups. The correlation check among indexes was done by linear correlation analysis. Results: Before treatment the number of people kept the upper number, and after treatment 10 patients with moderate and severe OSAHS and 25 healthy people were involved in the result analysis. 1 The serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with OSAHS (35 cases) were significantly higher than those in the control group (t=5.498, 9.626, P < 0.01), and the level of serum interleukin-10 was lower obviously than that in the control group (t=-4.667,P < 0.01). 2 The levels of serum interleukin-8 and monocyte chemoattractant protein-1 in patients with OSAHS had significantly positive correlation with apnea hypopnea index (r=0.671, 0.742, P < 0.01), and had negative correlation with lowest blood oxygen saturation (r=-0.442, -0.531, P < -0.01).The level of serum interleukin-10 had significantly negative correlation with apnea hypopnea index (r=-0.688, P < 0.01), and had positive correlation with lowest blood oxygen saturation (r=0.454, P < 0.01).3 The serum interleukin-10 and interleukin-8 had remarkably negative correlation with monocyte chemoatractant protein-1 (r=0.509, -0.666, P < 0.01), and the interleukin-8 had obviously positive correlation with monocyte chemoattractant protein-1 (r=0.706,P < 0.01). 4 The levels of serum in-terleukin-8 and monocyte chemoattractant protein-1 in patients of treat-ment group (10 cases)after half year treatment were lower significantly than those before treatment (t=4.896, 5.609, P < 0.01).The level of in-terleukin-10 was significantly higher than that before treatment (t=-4.625, P < 0.01). Conclusion: 1 The hypoxia induces the increase of serum interleukin-8 and monocyte chemoattractant protein-1, and the decrease of interleukin-10 in patients with OSAHS, which may join the occurrence of cardiovascular disease. 2 The nasal continuous positive airway treatment may reach the effect of preventing the occurrence of cardiovascular lesion in patients with OSAHS by means of relieving ischemia, decreasing the production of interleukin-8 and monocyte chemoattractant protein-1 and increasing the production of interleukin-10.

Correlation of serum 8-hydroxydeoxyguanylate level with disease severity and oxidative stress in osahs patients

[Relationship Between Serum Homocysteine Level and Oxidative Stress in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome].

Correlation Between Oxidative Stress and Obstructive Sleep Apnea-Hypopnea Syndrome

Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis

The relationship between obstructive sleep apnea-hypopnea syndrome and blood uric acid levels

Research on serum homocysteine level and its relationship with oxidative stress in elderly patients with obstructive sleep apnea/hypopnea syndrome and the inner mechanism

Clinical Study on Oxidation and Antioxidation in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Association Between Serum Homocysteine and Oxidative Stress in Elderly Patients with Obstructive Sleep Apnea/hypopnea Syndrome.

Neurocognitive Impairment is Correlated with Oxidative Stress in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Association between the circulating superoxide dismutase and obstructive sleep apnea: a meta-analysis

Influnce of Obstructive Sleep Apnea Hypopnea Syndrome to the Levels of Serum Uric Acid and Blood Lipid

Assessing the contribution of mild high-altitude exposure to obstructive sleep apnea-hypopnea syndrome comorbidities

Homocysteine Level in Patients with Obstructive Sleep Apnea/hypopnea Syndrome and the Impact of Continuous Positive Airway Pressure Treatment

Change and significance of 8-isoprostane in exhaled breath condensate in obstructive sleep apnea-hypopnea syndrome

Changes of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea hypopnea syndrome

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

Significance of DNA damage in peripheral blood lymphocytes of patients with OSAHS

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

Changes of Serum Adiponectin Level in Patients with Obstructive Sleep Apnea Hypopnea Syndrome and Its Relationship with Sleep Monitoring Indexes

Comparison of Ocular Surface Assessment Outcomes Between Healthy Controls and Patients with Obstructive Sleep Apnea–hypopnea Syndrome: a Meta-Analysis of the Literature